Risk factors

Anavex Life Sciences has accumulated a deficit of approximately $336 million with no commercial revenue and depends entirely on future funding to survive. The company faces heavy regulatory uncertainty for its drug candidates like ANAVEX®2-73 in neurodegenerative disorders and relies heavily on patent protection.

Global industrial packaging operations face heavy exposure to raw material price volatility, energy costs, and international geopolitical instability.

Limoneira faces severe agricultural risks from climate change, weather, pests like ACP, and water scarcity in California. The company is actively exploring strategic alternatives including potential sale or merger. Real estate development projects in California carry high regulatory, entitlement, and financing risks.

VMware integration and software execution are major risks alongside Broadcom’s semiconductor supply chain and customer concentration.

Customer concentration is material: the ten largest customers generated 57.9% of fiscal 2024 revenue.

Agilent relies heavily on global life sciences and pharmaceutical markets, international operations, and continuous new product introductions to drive growth.

The company relies heavily on key personnel, ongoing R&D investments for ARIA and HPP, and federal government contracts.

Pineapple Financial's risk profile is heavily weighted toward residential real estate market conditions, mortgage broker dependencies, and interest rate fluctuations. The company faces going concern uncertainties, operating losses, limited operating history, and potential delisting from the NYSE American. Currency exchange volatility between CAD and USD also impacts financial results.

Toll Brothers faces significant risks from economic and housing demand fluctuations, financing availability, and regional concentration in California. The company is vulnerable to rising interest rates, inflation impacting land and material costs, and joint venture exposures.

ABM Industries relies on a massive workforce subject to labor pressures and low-margin competitive bidding.

Concentrated reliance on a single product, avocados, exposes operations to supply, pricing, and agricultural volatility. High customer concentration is evidenced by top 10 customers accounting for 69 percent of net sales in fiscal 2024. International supply chains depend heavily on political stability and open borders in Mexico and Peru.

Clinical-stage biotechnology company dependent on the success of its lead genetic medicine candidate, detalimogene, for NMIBC.